| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.19 | 4e-05 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.003 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.004 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.099 | 0.005 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.14 | 0.006 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.13 | 0.006 |